Faeth Therapeutics, Inc. Shares Outstanding
Faeth Therapeutics, Inc. (FTH) had Shares Outstanding of 25.83 million shares as of 2026-06-30, per its 10-Q filed 2026-08-04.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-04
- 2026-06-30: Shares outstanding (split-adjusted) 25.83M shares; Shares authorized (split-adjusted) 300.00M shares.
- 2026-06-10: Shares outstanding (split-adjusted) (m); Shares authorized (split-adjusted) 300.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 1.34M shares; Shares authorized (split-adjusted) 12.50M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 1.26M shares; Shares authorized (split-adjusted) 12.50M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 25.83M shares 10-Q · filed 2026-08-04 | 300.00M shares 10-Q · filed 2026-08-04 |
| 2026-06-10 | (m) | 300.00M shares 10-Q · filed 2026-08-04 |
| 2026-03-31 | 1.34M shares 10-Q · filed 2026-05-15 | 12.50M shares 10-Q · filed 2026-05-15 |
| 2025-12-31 | 1.26M shares 10-Q · filed 2026-08-04 | 12.50M shares 10-Q · filed 2026-08-04 |
| 2025-09-30 | 1.26M shares 10-Q · filed 2025-11-14 | 12.50M shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 1.26M shares 10-Q · filed 2025-08-05 | 12.50M shares 10-Q · filed 2025-08-05 |
| 2025-06-16 | (m) | 12.50M shares 10-Q · filed 2026-05-15 |
| 2025-06-15 | (m) | 250.00M shares 10-Q · filed 2026-05-15 |
| 2025-03-31 | 25.21M shares 10-Q · filed 2025-05-06 | 250.00M shares 10-Q · filed 2025-05-06 |
| 2024-12-31 | 1.26M shares 10-K · filed 2026-03-30 | 12.50M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 25.15M shares 10-Q · filed 2024-11-14 | 250.00M shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 25.12M shares 10-Q · filed 2024-08-06 | 250.00M shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 25.07M shares 10-Q · filed 2024-05-09 | 250.00M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 25.03M shares 10-K · filed 2025-03-28 | 250.00M shares 10-K · filed 2025-03-28 |
| 2023-09-30 | 25.00M shares 10-Q · filed 2023-11-07 | 250.00M shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 26.58M shares 10-Q · filed 2023-08-03 | 250.00M shares 10-Q · filed 2023-08-03 |
| 2023-03-31 | 30.97M shares 10-Q · filed 2023-05-09 | 250.00M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 30.76M shares 10-K · filed 2024-02-29 | 250.00M shares 10-K · filed 2024-02-29 |
| 2022-09-30 | 30.72M shares 10-Q · filed 2022-11-08 | 250.00M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 30.72M shares 10-Q · filed 2022-08-09 | 250.00M shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 30.68M shares 10-Q · filed 2022-05-10 | 250.00M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 30.61M shares 10-K · filed 2023-03-29 | 250.00M shares 10-K · filed 2023-03-29 |
| 2021-09-30 | 30.59M shares 10-Q · filed 2021-11-10 | 1.23B shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 30.59M shares 10-Q · filed 2021-08-11 | 1.23B shares 10-Q · filed 2021-08-11 |
| 2021-03-31 | 30.59M shares 10-Q · filed 2021-05-13 | 1.23B shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 1.88M shares 10-K · filed 2022-03-15 | 250.00M shares 10-K · filed 2022-03-15 |
| 2020-01-31 | (m) | 1.23B shares 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |